US:
UK:
JAPAN:
- Report code : CMI-2831
- Industry : Biotechnology
- Published On : Jul 2019
- Pages : 177 Pages
- Format :
Press Release: Isothermal Nucleic Acid Amplification Technology (INAAT) Market to Surpass US$ 4,746.8 Million by 2026
Press Release: Isothermal Nucleic Acid Amplification Technology (INAAT) Market to Surpass US$ 4,746.8 Million by 2026
Global Isothermal Nucleic acid Amplification Technology (INAAT) Market Insights
Nucleic acid sequence-based amplification is a type of molecular biology, which is used to amplify RNA sequences. Isothermal Nucleic acid Amplification Technology (INAAT) is divided into several methods such as transcription mediated amplification, nucleic acid sequence-based amplification, signal mediated amplification of RNA technology, and others. Such many methods of isothermal nucleic acid amplification technology, in order to amplify the RNA sequences enable the market to grow at a meteoric growth during the forecast period.
The global isothermal nucleic acid amplification technology (INAAT) market was valued at US$ 1,724.0 million in 2018, and is expected to witness a CAGR of 13.6% during the forecast period (2019 – 2026).
Figure 1. Global Isothermal Nucleic acid Amplification Technology (INAAT) Market Share (%), by Product Type
Source: Coherent Market Insights Analysis (2019)
Collaboration strategies adopted by key players is expected to drive global isothermal nucleic acid amplification market growth
Increasing collaboration activities by key players is expected to boost global isothermal nucleic acid amplification technology (INAAT) market growth. For instance, in January 2017, Diagenode S.A. collaborated with Heidelberg University Hospital and the German Cancer Research Center (DKFZ). Under this collaboration Diagenode S.A focuses on development of high-sensitivity DNA amplification method. This method is for RNA sequencing library preparation solutions.
Moreover, key players in the market are focused on product launches for molecular diagnosis, which is expected to propel global isothermal nucleic acid amplification technology (INAAT) market growth. For instance, in April 2019, QuantaBio launched new freeze-dried lyophilized single-reaction reagent, Qscript lyo 1-step. Qscript lyo 1-step is a dry, stable, easy, and better 1-step RT-qPCR (quantitative reverse transcription polymerase chain reaction). It is highly sensitive and reproducible RT-qPCR. The reagent contains a thermo-stable polymerase.
Isothermal Nucleic acid Amplification Technology (INAAT) Market - Regional Analysis
North America isothermal nucleic acid amplification technology (INAAT) market is expected to account for the largest market share during the forecast period, owing to increasing product launch activities by key players. For instance, in September 2017, Bio-Rad Laboratories, Inc. launched RT-PCR (reverse transcriptase-polymerase chain reaction) kit in the U.S market. RT-PCR assay kit is a one-step procedure, where reverse transcription and gene amplification is performed in single tube. RT-PCR assay kit is used for DNA identification and amplification.
Furthermore, Asia pacific is expected to gain significant share in the global isothermal nucleic acid amplification technology (INAAT) market over the forecast period, owing to increasing launches of new products in this region. For instance, in July 2015, Takara Bio Inc., a Japanese company, launched real-time PCR system Thermal Cycler Dice Real Time System III. This system is used for rapid gene amplification. RT- PCR (reverse transcriptase-polymerase chain reaction) is used in various fields including food inspection, clinical examination, and personal genetic analysis.
Moreover, Europe is also projected to witness significant growth in the global isothermal nucleic acid amplification technology (INAAT) market, owing to increasing approval activities by regulatory authorities. For instance, in September 2017, Tetracore Inc. received an approval from European Economic Area (EEA) for its T-COR 8, which is a portable real-time PCR thermocycler. T-COR 8 is a molecular diagnostic platform used for detection and identification of infectious agents as well as nucleic acid amplification.
Figure 2: Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Value (US$ Mn), By Region
Source: Coherent Market Insights Analysis (2019)
Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market - Competitive Landscape
Key players operating in the isothermal nucleic acid amplification technology (INAAT) market include Alere Inc., Becton, Dickinson & Company, BioHelix Corporation, BioMerieux Biotechnology Company, Hologic Gene-Probe, QIAGEN Company, Thermo Fisher Scientific, Inc., Lucigen Corporation, Quidel Corporation, and NuGEN.
Isothermal nucleic acid technologies are used in recombinant DNA and molecular biology techniques. These techniques are used in detection and analysis of a small quantity of nucleic acids. Polymerases chain reaction is based on isothermal nucleic acid amplification technology. The polymerase chain reaction (PCR) is most widely used method for DNA amplification. Polymerase chain reaction (PCR) is used for the detection and identification of infectious diseases, genetic disorders, and for research purposes. PCR consists a thermocycling machine, which facilitates separation and amplification of DNA strands.
Market Dynamics
Increasing approvals from healthcare regulatory authorities for innovative technologies is expected to drive the global isothermal nucleic acid amplification technology (INAAT) market growth. For instance, in October 2018, Abbott laboratories received the U.S. Food and Drug Administration (FDA) for its next-generation Influenza A & B2 and Strep A2 molecular assays. These assays are used for the molecular detection and differentiation of influenza A and B virus. Next-generation Influenza A & B2 and Strep A2 molecular assays are currently available on ID NOW platform, which is a rapid isothermal system. It is used for the detection of infectious diseases such as influenza.
Furthermore, rising product launches by key players is expected to boost the global isothermal nucleic acid amplification technology (INAAT) market growth. For instance, in July 2017, TwistDx Inc. launched TwistAmp, a recombinase polymerase amplification (RPA) kit. It is used for DNA/RNA amplification. TwistAmp is an isothermal alternative to polymerase chain reaction PCR.
Key features of the study:
Detailed Segmentation:
“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
*Browse 33 market data tables and 31 figures on “Isothermal Nucleic Acid Amplification Technology (INAAT) Market” - Global forecast to 2026”.
Asia Pacific Intelligence Center (India): 